Zevra Therapeutics, Inc. Shares Outstanding (Cover Page)
Zevra Therapeutics, Inc. (ZVRA) had Shares Outstanding (Cover Page) of 59.38 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 59.38M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 59.12M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 58.71M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 56.30M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 59.38M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 59.12M shares 10-Q · filed 2026-05-06 |
| 2026-03-06 | 58.71M shares 10-K · filed 2026-03-09 |
| 2025-11-03 | 56.30M shares 10-Q · filed 2025-11-05 |
| 2025-08-08 | 56.14M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 54.68M shares 10-Q · filed 2025-05-13 |
| 2025-03-07 | 54.12M shares 10-K · filed 2025-03-12 |
| 2024-11-13 | 53.38M shares 10-Q · filed 2024-11-13 |
| 2024-08-12 | 52.62M shares 10-Q · filed 2024-08-14 |
| 2024-05-03 | 41.85M shares 10-Q · filed 2024-05-09 |
| 2024-03-30 | 43.43M shares 10-K · filed 2024-04-01 |
| 2023-11-03 | 36.22M shares 10-Q · filed 2023-11-07 |
| 2023-08-11 | 33.93M shares 10-Q · filed 2023-08-14 |
| 2023-05-08 | 33.88M shares 10-Q · filed 2023-05-15 |
| 2023-03-03 | 34.54M shares 10-K · filed 2023-03-07 |
| 2022-11-08 | 34.50M shares 10-Q · filed 2022-11-10 |
| 2022-08-11 | 34.49M shares 10-Q · filed 2022-08-12 |
| 2022-05-11 | 34.42M shares 10-Q · filed 2022-05-12 |
| 2022-03-29 | 34.42M shares 10-K · filed 2022-03-31 |
| 2021-11-09 | 35.32M shares 10-Q · filed 2021-11-10 |
| 2021-08-12 | 35.15M shares 10-Q · filed 2021-08-13 |
| 2021-05-12 | 28.51M shares 10-Q · filed 2021-05-14 |
| 2021-03-10 | 28.38M shares 10-K · filed 2021-03-12 |
| 2020-10-28 | 72.54M shares 10-Q · filed 2020-10-30 |
| 2020-08-11 | 72.46M shares 10-Q · filed 2020-08-12 |
| 2020-05-11 | 65.76M shares 10-Q · filed 2020-05-13 |
| 2020-02-26 | 50.68M shares 10-K · filed 2020-02-28 |
| 2019-11-14 | 33.22M shares 10-Q · filed 2019-11-14 |
| 2019-08-12 | 29.76M shares 10-Q · filed 2019-08-13 |
| 2019-05-13 | 28.52M shares 10-Q · filed 2019-05-14 |
| 2019-02-28 | 26.46M shares 10-K · filed 2019-03-01 |
| 2018-11-08 | 26.46M shares 10-Q · filed 2018-11-09 |
| 2018-08-09 | 16.04M shares 10-Q · filed 2018-08-10 |
| 2018-05-10 | 15.16M shares 10-Q · filed 2018-05-11 |
| 2018-03-28 | 15.10M shares 10-K · filed 2018-03-30 |
| 2017-11-08 | 14.66M shares 10-Q · filed 2017-11-09 |
| 2017-08-09 | 14.66M shares 10-Q · filed 2017-08-10 |
| 2017-05-19 | 14.65M shares 10-Q · filed 2017-05-22 |
| 2017-03-07 | 14.65M shares 10-K · filed 2017-03-10 |
| 2016-11-08 | 14.65M shares 10-Q · filed 2016-11-10 |
| 2016-08-09 | 14.65M shares 10-Q · filed 2016-08-11 |
| 2016-05-11 | 14.64M shares 10-Q · filed 2016-05-13 |
| 2016-03-11 | 14.50M shares 10-K · filed 2016-03-16 |
| 2015-11-11 | 14.45M shares 10-Q · filed 2015-11-13 |
| 2015-08-12 | 14.23M shares 10-Q · filed 2015-08-14 |
| 2015-05-28 | 14.23M shares 10-Q · filed 2015-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |